Novel four-CTL epitope-joined peptide

• 收藏
• 分享

专利权人:

Taiho Pharmaceutical Co.; Ltd.

发明人:

Fukaya, Satoshi,Osada, Toshihiro,Wada, Hiroshi

申请号：

AU2014337643

公开号：

AU2014337643B2

申请日:

2014.10.20

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

Provided is a cancer antigen peptide which it is possible to administer as a cancer peptide vaccine to a wide range of cancer patients, without the need for HLA testing, and with no limitation to patients having a specific HLA type. This four CTL epitope-joined peptide is obtained by joining, via linkers, of four CTL epitope peptides selected from a group of CTL epitope peptides derived from a tumor antigen molecule, and which have been reported to have CTL inducibility.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/